Pengaruh Pemberian Terapi Obat Anti Tubekulosis Fase Intensif Terhadap Kadar Hemoglobin pada Penderita Tuberkulosis di Kota Kupang
-
Yansensius Febrianto Ray Come(1*)
Universitas Nusa Cendana
-
Ika Febianti Buntoro(2)
-
Kresnawati Wahyu Setiono(3)
-
Elisabeth Levina Sari Setianingrum(4)
(*) Corresponding Author
Abstrak
ABSTRACT
Background : Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis infection. According to World Health Organization Report (WHO), TB was ranked as the tenth highest cause of death in the world at 2016. During therapy, patients with active TB for category I were given Isoniazid, Rifampicin, Pyrazinamide and Ethambutol for 2 months which is the intensive phase and 4 months for continuation phase. Various studies have showed intensive administration of Anti Tuberculosis Drugs (ATD) have a relationship with hemoglobin levels either increasing or decreasing hemoglobin levels in tuberculosis patients.
Objective : To find out the effect of ATD on hemoglobin levels in tuberculosis patients during the intensive phase of TB treatment in Kupang City
Methods : This study was an interventional study using the Quasy-Experimental One Group Pretest and Post Test research design to determine effect of ATD on hemoglobin levels in tuberculosis patients during the intensive phase of TB treatment conducted in 11 Primary Health Care in Kupang City by taking capillary blood to measured hemoglobin level. The sampling technique used consecutive sampling and the sample size is 48 people of lung tuberculosis patients. The study was analyzed univariately and bivariately using paired-t test.
Results : The results of data analysis of changes in hemoglobin levels before and after administration intensive phase of ATD showed significance value of p = 0.003 (p <0.05) with mean of ΔHb 0.88 gr/dl.
Conclusion : There is an effect of administration intensive phase of anti-tuberculosis therapy to hemoglobin levels in tuberculosis patients in Kupang City
##plugins.generic.usageStats.downloads##
Referensi
1. Kemenkes RI. Tuberkulosis Temukan Obati Sampai Sembuh. Infodatin 2016
2. World Health Organization.Global Tuberculosis Control: WHO Report 2016. Geneva,Switzerland: WHO;2016
3. Kemenkes RI. Profil Kesehatan Indonesia 2017. 32-36
4. Kemenkes RI. Riset Kesehatan Dasar Indonesia 2018. 80–90.
5. Kemenkes RI. Dinas Kesehatan Kota Kupang. Profil Kesehatan Kota Kupang 2018.
6. Kemenkes RI. Pedoman Nasional Pengendalian Tuberkulosis. 2014.
7. Kuswandi, Nanang Munif Yasin. Mengenal Obat Anti-Tuberkulosis. Yogyakarta:Balai Penerbit FK UGM. 2016.
8. Kassa E, Enawgaw B, Gelaw A, Gelaw B. Effect of anti-tuberculosis drugs on hematological profiles of tuberculosis patients attending at University of Gondar Hospital , Northwest Ethiopia. BMC Hematol [Internet]. BMC Hematology; 2016;1–11. Available from: http://dx.doi.org/10.1186/s12878-015-0037.1
9. Hadida M, Abosmhadana A, Draid M. Effects of Anti-Tuberculous Drugs on Liver Function Profile in Libyan Patients with Tuberculosis.The Egyptian Journal of Hospital Medicine. 2013;52(July):740–51.
10. Lee SW, Kang YA, Yoon YS, Um S, Lee SM, Yoo C, et al. The Prevalence and Evolution of Anemia Associated with Tuberculosis. J Korean Med Sci 2006;(12):1028–32.
11. Purnasari G. Anemia Pada Penderita Tuberkulosis Paru Anak Dengan Berbagai Status Gizi Dan Asupan Zat Gizi [skripsi] Semarang : Fakultas Kedokteran Universitas Diponegoro Semarang.2011
12. Nandra KD, Profil Hematologi Pasien Tuberkulosis Paru BTA Positif Kasus Baru Sebelum dan Sesudah Pemberian Obat Anti Tuberkulosis Kategori 1 Fase Intensif [thesis]. Jakarta : Fakultas Kedokteran Universitas Indonesia Program Studi Pulmonologi dan Ilmu Kedokteran Respirasi; 2014
13. Ulfi D.N, Perbedaan Kadar Hemoglobin Sebelum dan Sesudah Pemberian Obat Antituberkulosis Fase Awal [skripsi]. Yogyakarta : Fakultas Kedokteran dan Ilmu Kesehatan Universitas Muhammadyah Yogakarta.2014
14. Madu AJ, Ughasoro MD. Anaemia of Chronic Disease: An In-Depth Review. Med Princ Pract. 2017;26(1):19.doi:10.1159/000452104
15. Mexitalia M, Dewi YO, Pramono A, et al. Effect of tuberculosis treatment on leptin levels, weight gain and percentage body fat in Indonesian children. Korean J Pediatr. 2017; 60(4):118-123.16. Cronje L, Bornman L. Iron overload and tuberculosis: a case for iron chelation therapy. Int J Tuberc Lung Dis. 2005;9:2–9.
16. Cronje L, Bornman L. Iron overload and tuberculosis: a case for iron chelation therapy. Int J Tuberc Lung Dis. 2005;9:2–9.
17. Thuraidah A, Astuti RAW, Rakhmina D. Anemia Dan Lama Konsumsi Obat Anti Tuberculosis. Medical Laboratory Technology Journal; 2017;3(2):42–6.
18. A.V. Hoffbrand, J.E. Petit, P.A.H. Moss, Essential Hematology.Seven ed. Oxford, Blackwell Science Ltd 2016.
19. RJ, Kriz K, Desax M-C. Severe isoniazid related sideroblastic anemia. Hematology Reports. 2011;3(1):2.
##submission.copyrightStatement##
##submission.license.cc.by-nc-nd4.footer##Copyright Notice
This work is licensed under a Creative Commons Attribution 4.0 International License.
